Curdione has been reported to improve pulmonary fibrosis by inhibiting the activation of the TGF-β pathway, but experimental studies of this component against hepatic fibrosis have not been reported in the literature (Park et al., 2005; Liu et al., 2020). The gene discussed is TGFB1; the disease is Hepatic fibrosis.